Federal Register / Vol. 76, No. 213 / Thursday, November 3, 2011 / Notices 68167 

owner Scripps Research Institute, timely 

filed an application under 35 U.S.C. 

156(d)(5) for an additional interim 

extension of the term of U.S. Patent No. 

5,407,914. The patent claims the human 

drug product, SURFAXIN®

(lucinactant), and a method of using 

SURFAXIN® (lucinactant). The 

application indicates that a New Drug 

Application, NDA No. 21–746, for the 

human drug product SURFAXIN®

(lucinactant) has been filed, and is 

currently undergoing regulatory review 

before the Food and Drug 

Administration for permission to market 

or use the product commercially. 

Review of the application indicates 

that, except for permission to market or 

use the product commercially, the 

subject patent would be eligible for an 

extension of the patent term under 35 

U.S.C. 156, and that the patent should 

be extended for an additional one year 

as required by 35 U.S.C. 156(d)(5)(B). 

Because it is apparent that the 

regulatory review period will continue 

beyond the extended expiration date of 

the patent, November 17, 2011, interim 

extension of the patent term under 35 

U.S.C. 156(d)(5) is appropriate. 

An interim extension under 35 U.S.C. 

156(d)(5) of the term of U.S. Patent No. 

5,407,914 is granted for a period of one 

additional year from the extended 

expiration date of the patent, i.e., until 

November 17, 2012. 

Dated: October 28, 2011. 

Robert W. Bahr, 

Acting Associate Commissioner for Patent 

Examination Policy, United States Patent and 

Trademark Office. 

[FR Doc. 2011–28499 Filed 11–2–11; 8:45 am] 

BILLING CODE 3510–16–P 

DEPARTMENT OF COMMERCE 

United States Patent and Trademark 

Office 

[Docket No. PTO–C–2011–0069] 

National Medal of Technology and 

Innovation Nomination Evaluation 

Committee Meeting 

AGENCY: United States Patent and 

Trademark Office. 

ACTION: Notice of closed meeting. 

SUMMARY: The National Medal of 

Technology and Innovation (NMTI) 

Nomination Evaluation Committee will 

meet in closed session on Friday, 

November 18, 2011. The primary 

purpose of the meeting is to discuss the 

relative merits of persons, teams and 

companies nominated for the 2011 

NMTI Medal. 

DATES: The meeting will convene 

Friday, November 18, 2011, at 

approximately 9 a.m., and adjourn at 

approximately 5 p.m. 

ADDRESSES: The meeting will be held at 

the United States Patent and Trademark 

Office, 600 Dulany Street, Alexandria, 

VA 22314. 

FOR FURTHER INFORMATION CONTACT: 

Vikrum Aiyer, Program Manager, 

National Medal of Technology and 

Innovation Program, United States 

Patent and Trademark Office, 600 

Dulany Street, Alexandria, VA 22314; 

telephone (571) 272–8818, or by 

electronic mail: nmti@uspto.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act, 

5 U.S.C. app. 2, notice is hereby given 

that the NMTI Nomination Evaluation 

Committee, chartered to the United 

States Department of Commerce, will 

meet at the United States Patent and 

Trademark Office campus in 

Alexandria, Virginia. 

The Secretary of Commerce is 

responsible for recommending to the 

President prospective NMTI Medal 

recipients. The NMTI Nomination 

Evaluation Committee evaluates the 

nominations received pursuant to 

public solicitation and makes its 

recommendations for the Medal to the 

Secretary. Committee members are 

distinguished experts in the fields of 

science, technology, business and patent 

law drawn from both the public and 

private sectors and are appointed by the 

Secretary for three-year terms. 

The NMTI Nomination Evaluation 

Committee was established in 

accordance with the Federal Advisory 

Committee Act (FACA). The Committee 

meeting will be closed to the public in 

accordance with FACA and 5 U.S.C. 

552b(c)(4), (6) and (9)(B), because the 

discussion of the relative merit of the 

Medal nominations is likely to disclose 

information of a personal nature that 

would constitute a clearly unwarranted 

invasion of personal privacy; premature 

disclosure of the Committee’s 

recommendations would be likely to 

significantly frustrate implementation of 

the Medal Program; and the meeting 

will include a Department of Commerce 

Ethics Division presentation and 

question and answer session which may 

be closed to protect the privileged and 

confidential personal financial 

information of Committee members. 

The Chief Financial Officer and 

Assistant Secretary for Administration, 

United States Department of Commerce, 

formally determined on October 26, 

2011, pursuant to Section 10(d) of the 

Federal Advisory Committee Act, that 

the meeting may be closed because 

Committee members are concerned with 

matters that are within the purview of 

5 U.S.C. 552b(c)(4), (6) and (9)(B). Due 

to closure of this meeting, copies of any 

minutes of the meeting will not be 

available. A copy of the determination 

is available for public inspection at the 

United States Patent and Trademark 

Office. 

Dated: October 28, 2011. 

Teresa Stanek Rea, 

Deputy Under Secretary of Commerce for 

Intellectual Property and Deputy Director of 

the United States Patent and Trademark 

Office. 

[FR Doc. 2011–28500 Filed 11–2–11; 8:45 am] 

BILLING CODE 3510–16–P 

COMMODITY FUTURES TRADING 

COMMISSION 

Sunshine Act Meeting—Emergency 

Meeting Notice 

This notice that an emergency 

meeting was held is published pursuant 

to the provisions of the Government in 

the Sunshine Act, Public Law 94–409, 

5 U.S.C. 552b. 

AGENCY HOLDING THE MEETING: 

Commodity Futures Trading 

Commission. 

TIME AND DATE: The Commission held an 

emergency closed meeting on October 

31, 2011 at 12 p.m. The Commission, by 

a recorded unanimous vote, determined 

that the agency business required that 

business of the agency required that the 

meeting be held at that time. 

PLACE: Three Lafayette Center, 1155 

21st St. NW., Washington, DC, 9th Floor 

Commission Conference Room. 

STATUS: Closed. 

MATTERS TO BE CONSIDERED: Registrant 

Financial Matters. 

CONTACT PERSON FOR MORE INFORMATION: 

Sauntia S. Warfield, Assistant Secretary 

of the Commission, 202–418–5084. 

Sauntia S. Warfield, 

Assistant Secretary of the Commission. 

[FR Doc. 2011–28607 Filed 11–1–11; 11:15 am] 

BILLING CODE 6351–01–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

[CPSC Docket No. 12–C0003] 

Spin Master, Inc. and Spin Master, Ltd., 

Provisional Acceptance of a 

Settlement Agreement and Order 

AGENCY: Consumer Product Safety 

Commission. 

ACTION: Notice. 


srobinson on DSK4SPTVN1PROD with NOTICES